During the test, inhalation and exhalation create a repeated respiratory challenge to cardiovascular control. Heart rate normally accelerates as the subject inhales and decelerates during exhalation, producing respiratory sinus arrhythmia. The magnitude and consistency of this alternating response are important because they reflect how effectively parasympathetic, or vagal, input modulates cardiac timing during changing respiratory phases.
The key readout is the heart-rate difference between the breathing phases or a related measure of heart-rate variability. A larger phase-related fluctuation indicates greater expression of cardiac vagal modulation in that recording, whereas a reduced fluctuation suggests a weaker parasympathetic response. This interpretation concerns autonomic regulation specifically, rather than serving as a complete measure of cardiovascular function.
Pharmacological studies can use the response as a functional marker of drug-related autonomic effects. If a compound changes the size of the breathing-linked heart-rate response, investigators can examine whether treatment alters cardiac vagal control or broader cardiovascular reflexes. Comparing results before and after treatment helps characterize change, while interpretation should account for other physiological measurements rather than isolating the test result.
An assessment follows repeated, controlled cycles of deep inspiration and expiration while heart rate is recorded. The investigator then compares the rate during inhalation with the rate during exhalation and calculates the phase-related difference or resulting variability. Because the signal depends on the breathing pattern, maintaining the prescribed paced cycle is central to obtaining a response that can be interpreted as an autonomic measure.
In pharmacology, the test is useful when a study needs a noninvasive indicator of treatment-related autonomic change. It can characterize how drugs influence parasympathetic cardiovascular regulation and can be used to assess whether treatment is associated with altered cardiovascular reflexes. This makes the measurement relevant to drug-effect studies and to investigations of autonomic dysfunction, without requiring an invasive autonomic assessment.
Results are most informative when integrated with other physiological measurements. A reduced or altered breathing-linked response may point to changed parasympathetic regulation, but it can also occur alongside broader cardiovascular abnormalities. Combining the test with additional measures helps investigators distinguish a predominantly vagal change from a more general cardiovascular disturbance and strengthens interpretation of drug- or disease-related findings.